MedPath

Evaluation of the effects of Cydonia Oblonga Mill. fruit syrup on reduction of Biochemical complications induced by Herceptin in patients with breast cancer

Phase 1
Conditions
Breast cancer.
Registration Number
IRCT20200427047219N2
Lead Sponsor
Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
60
Inclusion Criteria

The desire to participate in the study
Breast cancer in the early stages of the disease
HER2 positive
Women over 18 years
Life expectancy more than 3 months (with a doctor's diagnosis)
A person should at least be able to walk and do their own thing (WHO performance status 0-2)

Exclusion Criteria

Suffering from other cancers
Thyroid or kidney disorders
Get other vitamin or mineral supplements
Patients with a body mass index less than 18.5
Lack of willingness to continue participating in the project for any reason

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Biochemical factors including: ALP,GGT,ALT, AST. Timepoint: At the beginning of the experiment and 3 months after the intervention. Method of measurement: Laboratory kits.
Secondary Outcome Measures
NameTimeMethod
Biochemical factors. Timepoint: Start of study (before the start of the intervention) and 3 months later. Method of measurement: Laboratory kits.
© Copyright 2025. All Rights Reserved by MedPath